Please go to the PowerPak homepage
and select a course.
Primer on Prevention and Treatment of HIV Infection
This activity is for pharmacist and is sponsored by Postgraduate Healthcare Education, LLC (PHE).
There has been no commercial support for this activity.
David Cluck, PharmD, BCPS, AAHIVP
Associate Professor of Pharmacy Practice
Bill Gatton College of Pharmacy
East Tennessee State University
David Cluck hereby state that they have no relevant affiliation or financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.
The following reviewers, Emily C. Huesgen, PharmD, BCACP, AAHIVP, and L. Michael Posey, BSPharm, MA, hereby state they have no relevant affiliation or financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.
Susanne Batesko, RN, BSN, Robin Carrino, L. Michael Posey, BSPharm, MA, and Jeannette Wick, BSPharm, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credits: 3.0 hours (0.20 ceu)
Type of Activity: Knowledge
Fee Information: $6.97
Estimated time to complete activity: 180 minutes
This course is approved by the Florida Board of Pharmacy, provider number 50-17869. CE Broker Course ID: 20-637557
Postgraduate Healthcare Education, LLC reports registered course completions by Florida license holders to the CE Broker System.
January 8, 2019
January 8, 2022
This accredited activity has been designed for pharmacists.
HOW TO EARN CREDIT
During the period January 8, 2019 through January 8, 2022, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the posttest and the evaluation form online. To answer the questions, go to www.PowerPak.com and access the activity. Click on the "View Content" and then "Take Exam" buttons at the bottom of the page; click on your selected choice for each answer then proceed to the next question. Once completed, click on Submit Posttest at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
To educate pharmacists about prevention and treatment of human immunodeficiency virus (HIV) infection and review Florida-specific legislation related to HIV testing requirements.
Upon completion of this activity, participants should be better able to:
- Discuss the epidemiology of HIV infection including trends related to incidence and transmission
- Summarize opportunistic infections associated with HIV/acquired immunodeficiency syndrome (AIDS)
- Outline infection control practices for HIV infection as well as nonpharmacologic and pharmacologic methods of prevention
- Review preferred antiretroviral drug regimens for treatment-naive and treatment-experienced patients
- Describe HIV testing-related requirements of the Florida Omnibus AIDS Act
REQUIRED COMPUTER HARDWARE/SOFTWARE
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5
Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without an evaluation of their patients' conditions and current medications, including the identification of possible contraindications regarding the dangers of use and a review of any applicable manufacturer's product information, as well as a comparison with the recommendations of other authorities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.